Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roberto L. Patron
Combinations of Vancomycin and Β-Lactams Are Synergistic Against Staphylococci With Reduced Susceptibilities to Vancomycin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Synergistic Killing of Vancomycin-Resistant Enterococci of Classes A, B, and C by Combinations of Vancomycin, Penicillin, and Gentamicin.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antimicrobial Activity of Ceftaroline Tested Against Staphylococci With Reduced Susceptibility to Linezolid, Daptomycin, or Vancomycin From U.S. Hospitals, 2008 to 2011
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Β-Lactams Enhance Daptomycin Activity Against Vancomycin-Resistant Enterococcus Faecalis and Enterococcus Faecium inIn VitroPharmacokinetic/Pharmacodynamic Models
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Vancomycin and Oxacillin Co-Resistance of Commensal Staphylococci
Jundishapur Journal of Microbiology
Infectious Diseases
Microbiology
Combinations of Β-Lactam or Aminoglycoside Antibiotics With Plectasin Are Synergistic Against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus Aureus
PLoS ONE
Multidisciplinary
Activity of AZD2563, a Novel Oxazolidinone, Against Staphylococcus Aureus Strains With Reduced Susceptibility to Vancomycin or Linezolid
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Morphological and Genetic Differences in Two Isogenic Staphylococcus Aureus Strains With Decreased Susceptibilities to Vancomycin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Synergy and Postantibiotic Effect of Colistin Combinations With Meropenem and Vancomycin Against Enterobacteriaceae With Multiple Carbapenem Resistance Mechanisms
Journal of Infection and Chemotherapy
Infectious Diseases
Microbiology
Pharmacology
Lipophilic Teicoplanin Pseudoaglycon Derivatives Are Active Against Vancomycin- And Teicoplanin-Resistant Enterococci
Journal of Antibiotics
Drug Discovery
Pharmacology
